154 related articles for article (PubMed ID: 30695317)
21. Short- and Long-Term Biological Variability of Small Dense LDL, HDL3, and Triglyceride-Rich Lipoprotein Cholesterol.
Fatica EM; Jenkins SM; Scott RJ; Block DR; Meeusen JW; Baumann NA; Saenger AK; Donato LJ
J Appl Lab Med; 2022 Sep; 7(5):1047-1061. PubMed ID: 35899495
[TBL] [Abstract][Full Text] [Related]
22. Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease.
Huang YC; Chang PY; Hwang JS; Ning HC
Biomed J; 2014; 37(6):375-9. PubMed ID: 25179702
[TBL] [Abstract][Full Text] [Related]
23. The role of small dense LDL-C/large buoyant LDL-C ratio as an independent risk factor in patients with type 2 diabetes mellitus and metabolic syndrome.
Wang C; Li Y; Peng P; Lin H; Zhu Y; Xu X; Wu P; Zhang Y; Xu T; Ren J; Xu H; Dong G; Xu Y; Jiang H; Zhao J; Zhai Y; Zai G
Ann Biol Clin (Paris); 2024 Jun; 82(2):174-186. PubMed ID: 38832689
[TBL] [Abstract][Full Text] [Related]
24. LDL particle size, fat distribution and insulin resistance in obese children.
Miyashita M; Okada T; Kuromori Y; Harada K
Eur J Clin Nutr; 2006 Mar; 60(3):416-20. PubMed ID: 16278685
[TBL] [Abstract][Full Text] [Related]
25. [Metabolic syndrome and small dense LDL-cholesterol].
Hirano T
Rinsho Byori; 2007 May; 55(5):434-8. PubMed ID: 17593688
[TBL] [Abstract][Full Text] [Related]
26. The small dense LDL particle/large buoyant LDL particle ratio is associated with glucose metabolic status in pregnancy.
Chen Y; Du M; Xu J; Chen D
Lipids Health Dis; 2017 Dec; 16(1):244. PubMed ID: 29241449
[TBL] [Abstract][Full Text] [Related]
27. Small Dense Low Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women: Quality or Quantity?
Mogarekar MR; Kulkarni SK
Arch Med Res; 2015 Oct; 46(7):534-8. PubMed ID: 26348135
[TBL] [Abstract][Full Text] [Related]
28. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
29. Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths.
Kang HS; Gutin B; Barbeau P; Litaker MS; Allison J; Le NA
Int J Obes Relat Metab Disord; 2002 Aug; 26(8):1030-5. PubMed ID: 12119567
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a new homogenous method for detection of small dense LDL cholesterol: comparison with the LDL cholesterol profile obtained by density gradient ultracentrifugation.
Albers JJ; Kennedy H; Marcovina SM
Clin Chim Acta; 2011 Mar; 412(7-8):556-61. PubMed ID: 21156166
[TBL] [Abstract][Full Text] [Related]
31. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
32. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions.
Anagnostis P; Stevenson JC; Crook D; Johnston DG; Godsland IF
Maturitas; 2015 May; 81(1):62-8. PubMed ID: 25804951
[TBL] [Abstract][Full Text] [Related]
33. Validation of Estimated Small Dense Low-Density Lipoprotein Cholesterol Concentration in a Japanese General Population.
Endo K; Kobayashi R; Tanaka M; Tanaka M; Akiyama Y; Sato T; Hosaka I; Nakata K; Koyama M; Ohnishi H; Takahashi S; Furuhashi M
J Atheroscler Thromb; 2024 Jun; 31(6):931-952. PubMed ID: 38171805
[TBL] [Abstract][Full Text] [Related]
34. Estimation of plasma small dense LDL cholesterol from classic lipid measures.
Srisawasdi P; Chaloeysup S; Teerajetgul Y; Pocathikorn A; Sukasem C; Vanavanan S; Kroll MH
Am J Clin Pathol; 2011 Jul; 136(1):20-9. PubMed ID: 21685028
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio.
Granot E
Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934
[TBL] [Abstract][Full Text] [Related]
36. Small dense low density lipoprotein-cholesterol and cholesterol ratios to predict arterial stiffness progression in normotensive subjects over a 5-year period.
Li G; Wu HK; Wu XW; Cao Z; Tu YC; Ma Y; Wang WQ; Cheng J; Zhou ZH
Lipids Health Dis; 2018 Feb; 17(1):27. PubMed ID: 29433526
[TBL] [Abstract][Full Text] [Related]
37. Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles.
Winkler K; Schewe T; Pütz G; Odünc N; Schäfer G; Siegel E; Geisen U; Abletshauser C; Hoffmann MM
Eur J Clin Invest; 2009 Jun; 39(6):463-70. PubMed ID: 19397693
[TBL] [Abstract][Full Text] [Related]
38. Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.
Thongtang N; Diffenderfer MR; Ooi EMM; Barrett PHR; Turner SM; Le NA; Brown WV; Schaefer EJ
J Lipid Res; 2017 Jul; 58(7):1315-1324. PubMed ID: 28392500
[TBL] [Abstract][Full Text] [Related]
39. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
40. Hypertriglyceridemia is a major factor associated with elevated levels of small dense LDL cholesterol in patients with metabolic syndrome.
Cho Y; Lee SG; Jee SH; Kim JH
Ann Lab Med; 2015 Nov; 35(6):586-94. PubMed ID: 26354346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
